Charles Elliott Sigal

Companies

• Alnylam PharmaceuticalsBoard member Aug 24, 2022 to now¹
• VIR BiotechnologyBoard member Jul 14, 2020 to now²
• Surface Oncology, Inc.Board member Apr 18, 2018 to Sep 8, 2023³
• Adaptimmune (United Kingdom)Board member Jan 4, 2016 to Jul 3, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY3,446 shares⁵$811.8K at $235.58May 22, 2026
• VBVIR Biotechnology VIR49,806 shares⁶$509.8K at $10.23May 28, 2026
• SOSurface Oncology, Inc.0 shares⁷Sep 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 27, 2026Granted 8,000 shares of VIR Biotechnology⁶
• May 20, 2026Granted 671 shares of Alnylam Pharmaceuticals⁵
• May 30, 2025Granted 8,000 shares of VIR Biotechnology⁸
• May 8, 2025Granted 775 shares of Alnylam Pharmaceuticals⁹
• May 30, 2024Granted 8,000 shares of VIR Biotechnology¹⁰
• Sep 8, 2023Returned to company 45,453 shares of Surface Oncology, Inc.⁷
• May 22, 2023Granted 6,027 shares of VIR Biotechnology¹¹
• Mar 1, 2023Bought 2,500 shares at $22.73 of VIR Biotechnology¹²
• Jan 5, 2023Bought 2,500 shares at $24.96 of VIR Biotechnology¹³
• Jan 4, 2023Bought 2,500 shares at $25.25 of VIR Biotechnology¹⁴
• Jan 3, 2023Bought 2,500 shares at $25.60 of VIR Biotechnology¹⁴
• May 23, 2022Granted 6,405 shares of VIR Biotechnology¹⁵